www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Urgent: 20 schools, police station, official building torched in southern Thailand    URGENT: Thousands feared dead in train collision in DPRK    Beijing reports one SARS suspect case    UN council fails to adopt resolution backing Cyprus unity plan     Urgent: UN council to vote on resolution backing Cyprus unity plan    Urgent: UN council endorses probe of oil-for-food program    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Metrolife  
Travel  
Weather  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones

   News Photos Voice People BizChina Feature About us   
UNICEF calls for reducing price of new anti-malaria drug
www.chinaview.cn 2004-04-23 02:03:23

    ADDIS ABABA, April 22 (Xinhuanet) -- The United Nations Children's Fund (UNICEF) Thursday called on pharmaceutical firms and donor countries to reduce the price of a new anti-malaria drug, to get behind an initiative to introduce the life-saving drug to hundreds of millions of people.

    According to a press release issued by UNICEF, the powerful new drug called artemisinin-containing combination therapy (ACT) can save the lives of 300 million people afflicted by malaria every year. But it is comparatively expensive and currently available only in limited quantities.


    "If the private and public sectors work together effectively, we can quickly reshape the marketplace for malaria drugs and take a great leap toward rolling back malaria," said Executive Director of UNICEF Carol Bellamy before the Africa Malaria Day to be marked on April 25.

    UNICEF and partners are working with global manufacturers to expand the production of high quality ACTs so that every child and community that needs these drugs can access them readily, it said.

    Chloroquine, the least expensive and most widely used anti-malaria drug, has lost its effectiveness in many parts of Africa, the press release said.

    Malaria, a mosquito-borne disease, claims lives of over one million children every year, most of whom under the age of five, according to the release. Enditem 

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.